SUBSCRIBE
SUBSCRIBE

Australia

This Biotech Aims To Transform The Diagnosis Of Mental Illness. Michael Phelps Backs It. Can It Really Work?
July 21, 2017
 · 
1 min read
Ansell Implements $100 Million Restructuring After Sale of Condom Biz
July 20, 2017
 · 
1 min read
Genetown
Why You Should Always Question the Hiring Manager During An Interview
July 19, 2017
 · 
1 min read
Genetown
5 Tips for Increasing Your Chance Of Being Headhunted
July 19, 2017
 · 
1 min read
Genetown
5 Key Elements Of A Resume That Will Make A Great First Impression
July 19, 2017
 · 
1 min read
Genetown
How A Scientist With A PhD Is An Advantage At A Job Interview
July 19, 2017
 · 
1 min read
Genetown
How To Advance Your Scientific Career By Working For A CRO
July 19, 2017
 · 
1 min read
Science May Just Have Found A Way To Treat The Flu And Common Cold, Nature Communications Reveals
July 13, 2017
 · 
1 min read
Job Trends
AstraZeneca PLC Sold Its U.S. HQ But Will Spend $100 Million Expanding Its Australia Facility
July 12, 2017
 · 
1 min read
Let's Get Rid Of Clinical Trials - Part 2
BioMidwest
BioPharm Executive: And So It Continues: Let’s Get Rid of Clinical Trials (Part 2)
July 7, 2017
 · 
4 min read
Load More
PRESS RELEASES
Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®
November 13, 2023
 · 
8 min read
Business
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
November 13, 2023
 · 
8 min read
Drug Development
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
November 12, 2023
 · 
8 min read
Drug Development
Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
November 9, 2023
 · 
6 min read
Drug Development
Recce Pharmaceuticals Completes Dosing First Subjects at 15-Minute Infusion Rate in a Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
November 9, 2023
 · 
3 min read
Opthea to Present at the Jefferies 2023 London Healthcare Conference
November 9, 2023
 · 
2 min read
Telix to Present at Jefferies London Healthcare Conference 2023
November 8, 2023
 · 
4 min read
Drug Development
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
November 8, 2023
 · 
6 min read
AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer
November 7, 2023
 · 
3 min read
Propanc Biopharma Confirms PRP Enhances Chemosensitivity and Alters Tumor Microenvironment of Pancreatic Tumor Cells
November 7, 2023
 · 
4 min read
Drug Development
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
November 7, 2023
 · 
7 min read
Drug Development
Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer
November 6, 2023
 · 
3 min read
BioCina Expands Partnership with GPN Vaccines
November 6, 2023
 · 
3 min read
Drug Development
Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung Cancer
November 3, 2023
 · 
5 min read
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients.
November 2, 2023
 · 
3 min read
Immutep to Participate in November 2023 Investor Events
November 2, 2023
 · 
1 min read
Drug Development
KAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING PHASE 2 STUDY OF PAXALISIB IN PRIMARY CNS LYMPHOMA
November 1, 2023
 · 
6 min read
Business
Immutep Quarterly Activities Report Q1 FY24
October 31, 2023
 · 
8 min read
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS
October 31, 2023
 · 
4 min read
Immuron CEO Steven Lydeamore presented at AusBioInvest
October 30, 2023
 · 
1 min read
Load More